Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Myelofibrosis (MF) is a chronic myeloproliferative neoplasm characterized by anemia, splenomegaly, constitutional symptoms, etc. Allogeneic hematopoietic stem cell transplantation ···【more】
Article source：Captain MedicineRelease date：2024-11-27Recommended：490
Selinexor's high-profile therapeutic drug has once again ignited a flame of hope in the hearts of patients and medical professionals. As a bright star in the field of medicine ···【more】
Article source：Captain MedicineRelease date：2024-11-27Recommended：498
Dose adjustment regimen for selinexor in the treatment of diffuse large B-cell lymphomaGeneral dose adjustment:· Starting dose: 60 mg on days 1 and 3 of each week (120 mg total per···【more】
Article source：Captain MedicineRelease date：2024-11-26Recommended：537
How many generic drugs are there in Laos Lucius Selineso?This study aims to determine the optimal dose of Selinexor in combination with pomalidomide and dexamethasone (SPd). The st···【more】
Article source：Captain MedicineRelease date：2024-11-26Recommended：470
The price of generic capmatinib in LaosCapmatinib has been approved for the treatment of MET exon 14-mutated non-small cell lung cancer based on demonstrated efficacy in a patient ···【more】
Article source：Captain MedicineRelease date：2024-11-25Recommended：504
There are several generic versions of the Laos Lucius version of capmatinibMET dysregulation occurs in up to 26% of patients with non-small cell lung cancer (NSCLC) after treatment···【more】
Article source：Captain MedicineRelease date：2024-11-25Recommended：472
Gilteritinib, as a FLT3 inhibitor, has demonstrated significant clinical activity in patients with FLT3-mutated (FLT3mut) relapsed/refractory (R/R) acute myeloid leukemia (AML). To···【more】
Article source：Captain MedicineRelease date：2024-11-22Recommended：411
This study aims to investigate the safety and efficacy of the combination of gilteritinib as a strategy to bridge to allogeneic hematopoietic stem cell transplantation (allo-HSCT) ···【more】
Article source：Captain MedicineRelease date：2024-11-22Recommended：491
What are the side effects of gilitinib?The FLT3 inhibitor Gilteritinib (Xospata) has resulted in significant survival improvements in patients with relapsed/refractory acute myeloi···【more】
Article source：Captain MedicineRelease date：2024-11-21Recommended：409
Gireltinib is primarily effective in acute myeloid leukemia (AML), particularly in relapsed or refractory AML harboring FLT3 mutations.InhibitionGireltinib is a novel, highly selec···【more】
Article source：Captain MedicineRelease date：2024-11-21Recommended：402
Patients with non-small cell lung cancer (NSCLC) with anaplastic lymphoma kinase (ALK) rearrangement or ROS proto-oncogene 1 (ROS1) rearrangement are generally sensitive to tyrosin···【more】
Article source：Captain MedicineRelease date：2024-11-20Recommended：452
Lorlatinib is a highly potent third-generation ALK and ROS1 tyrosine kinase inhibitor with good brain penetration and broad coverage of ALK mutations. In a phase 1 study, it showed···【more】
Article source：Captain MedicineRelease date：2024-11-20Recommended：521
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：[list:visits]2024-09-07
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended：[list:visits]2026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended：[list:visits]2026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended：[list:visits]2026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended：[list:visits]2026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended：[list:visits]2026-31-07
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】
Recommended：[list:visits]2026-30-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
